Recent studies showed that arsenic trioxide (As 2 O 3 ) could induce apoptosis and partial differentiation of leukemic promyelocytes. Here, we addressed the possible mechanisms underlying these two different effects. 1.0 M As 2 O 3 -induced apoptosis was associated with condensation of the mitochondrial matrix, disruption of mitochondrial transmembrane potentials (⌬⌿m) and activation of caspase-3 in acute promyelocytic leukemia (APL) cells regardless of their sensitivity to all-trans retinoic acid (ATRA). All these effects were inhibited by dithiothreitol (DTT) and enhanced by buthionine sulfoximine (BSO). Furthermore, BSO could also render HL60 and U937 cells, which had the higher cellular catalase activity, sensitive to As 2 O 3 -induced apoptosis. Surprisingly, 1.0 M As 2 O 3 did not induce the ⌬⌿m collapse and apoptosis, while 0.1 M As 2 O 3 induced partial differentiation of fresh BM cells from a de novo APL patient. In this study, we also showed that 0.2 mM DTT did not block low-dose As 2 O 3 -induced NB4 cell differentiation, and 0.1ෂ0.5 M As 2 O 3 did not induce differentiation of ATRA-resistant NB4-derived sublines, which were confirmed by cytomorphology, expression of CD11b, CD33 and CD14 as well as NBT reduction. Another interesting finding was that 0.1ෂ0.5 M As 2 O 3 could also induce differentiation-related changes in ATRA-sensitive HL60 cells. However, the differentiationinducing effect could not be seen in ATRA-resistant HL60 sublines with RAR␣ mutation. Moreover, low-dose As 2 O 3 and ATRA yielded similar gene expression profiles in APL cells. These results encouraged us to hypothesize that As 2 O 3 induces APL cell differentiation through direct or indirect activation of retinoic acid receptor-related signaling pathway(s), while ⌬⌿m collapse is the common mechanism of As 2 O 3 -induced apoptosis. Leukemia (2000) 14, 262-270.
Introduction
Arsenic trioxide (As 2 O 3 ), an effective drug for the treatment of acute promyelocytic leukemia (APL), [1] [2] [3] [4] was shown to exert dose-dependent dual effects in APL cells, ie triggering apoptosis and inducing partial differentiation. [5] [6] [7] [8] Meanwhile, it was also suggested that these effects were associated with As 2 O 3 -induced modulation/degradation of PML-RAR␣ protein, 5, [8] [9] [10] [11] [12] an APL-specific fusion protein resulting from the reciprocal chromosome translocation t(15;17)(q22;q21). 13, 14 However, high-dose (1.0ෂ2.0 M) As 2 O 3 could also induce in vitro growth inhibition and/or apoptosis of malignant lymphocytes, myeloma cells, and some solid tumor cell lines such as oesophageal carcinoma and neuroblastoma. [15] [16] [17] [18] [19] [20] [21] Obviously, As 2 O 3 -induced apoptosis may involve some common mechanisms. Recently, it was suggested that As 2 O 3 -induced collapse of mitochondrial transmembrane potential (⌬⌿m) via a direct effect on the mitochondrial permeability transition pore (PT) was a pivotal event in As 2 O 3 -induced apoptosis, and sulfhydryl (−SH) groups could be important targets of As 2 O 3 for induction of ⌬⌿m collapse and apoptosis. 18, 22 However, a recent report showed that GSH reducer dithiothreitol (DTT) effectively enhanced As 2 O 3 -induced apoptosis in APL cell line NB4 cells, 23 which was inconsistent with the observation in malignant lymphocytes. 18 Therefore, it is necessary to evaluate further the role of −SH groups in As 2 O 3 -induced apoptosis.
On the other hand, the mechanisms of low-dose (0.1ෂ0.5 M) As 2 O 3 -induced differentiation, which was observed selectively in APL cells and is possibly the most important mechanism for the remission induction of APL, remain obscure. Therefore, its illustration is important to understand the clinical potential of As 2 O 3 in the treatment of cancers. In the present work, a series of cell biological and biochemical studies were conducted on APL-derived cell lines and HL60 cells with and without the mutation of retinoic acid receptor-␣ (RAR␣). Our results urged us to propose that −SH oxidation-related ⌬⌿m collapse and caspase-3 activation contributes to As 2 O 3 -induced apoptosis of APL cells, while As 2 O 3 -induced differentiation might be mediated through direct or indirect activation of RAR␣-related signal pathway(s).
Materials and methods

Reagents
As 2 O 3 , ATRA, dithiothreitol (DTT, a widely used disulfide bond-reducing agent) and buthionine sulfoximine (BSO, a selective inhibitor of ␥-glutamylcysteine synthetase) were purchased from Sigma Chemical Company (St Louis, MO, USA). As 2 O 3 was dissolved in small amounts of 1.0 M NaOH, then diluted to 5.0 mM with phosphate-buffered saline (PBS) as stock solutions.
Cell culture, viability and morphology
Fresh bone marrow (BM) cells from two cases of de novo APL patients, with informed consent, were separated by centrifugation on Ficoll's solution. In these two samples, over 85% of cells were leukemic promyelocytes with chromosome translocation t(15;17) and PML-RAR␣ transcripts revealed by cytogenetics and RT-PCR analysis. Both patients were treated with ATRA and achieved clinical remission. Cell lines used in this study included ATRA-sensitive APL cell line (NB4), ATRAresistant NB4-derived sublines (MR2, R1, R2) and other myeloid leukemia cell lines (HL60 and U937). In addition, HL60 sublines with the dominant-negative mutation of RAR-␣ (HL60 Res ), kindly provided by R Gallagher, 24 were also used as in vitro models. All cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS; Gibco BRL, Grand Island, NY, USA), glutamine and antibiotics (100 IU/ml penicillin and 100 g/ml streptomycin) in a humidified atmosphere of 95% air/5% CO 2 at 37°C. To avoid possible effects of cell density on cell growth and survival, cells were maintained at less than 5 × 10 5 cells/ml with daily adjusting cell density through adding fresh medium and corresponding concentrations of compounds. Cell viability was estimated by trypan-blue exclusion. Morphology was determined with Wright's staining of cells centrifuged on to slides by cytospin (Shandon, Runcorn, UK; 500 r.p.m., 4 min).
DNA content analysis by flow cytometry
Cells were collected, rinsed and injected into cold 70% ethanol, then kept overnight at 4°C. Subsequently, cells were rinsed with PBS, treated with Tris-HCl buffer (pH 7.4) supplemented with 1% RNase and stained with propidium iodide (PI, 50 g/ml). Distribution of cells with different DNA contents was determined by flow cytometry (Becton Dickinson, San Jose, CA, USA). Ten thousand cells were analyzed in every sample. All data were collected, stored and analyzed by LYSIS II software (Becton Dickinson).
Gel electrophoresis of genomic DNA
A total of 10 6 cells were lysed with 2 ml lysis buffer (50 mM Tris-HCl pH 8, 20 mM EDTA pH 8 and 2% SDS) overnight at 37°C. Then, 0.8 ml saturated NaCl solution was added and centrifuged twice to remove proteins. RNase was added to supernatants at a final concentration of 20 g/ml and incubated at 37°C for 15 min. DNA was precipitated by adding two volumes of 70% ethanol and electrophoresed overnight on a 1.25% agarose gel.
Determination of mitochondrial transmembrane potentials (⌬⌿m) on flow cytometry
After washing twice with PBS, about 10 6 cells were incubated (37°C, 30 min) with 10 g/ml rhodamine 123 (Rh123), a cationic lipophilic fluorochrome taken up by mitochondria in proportion to the ⌬⌿m. Then, 50 g/ml PI, a membraneimpermeable DNA-binding dye, was added to cells. Fluorescent intensities were determined on flow cytometry (Becton Dickinson). Ten thousand cells were analyzed in every sample. All data were collected, stored and analyzed by LYSIS II software (Becton Dickinson).
Transmission electron microscopy (TEM)
Cells were fixed in suspension with 2.5% glutaraldehyde at 4°C overnight, and post-fixed for 1 h on ice with 1% OsO 4 . Then, cells were dehydrated, infiltrated and embedded according to the usual methods. The sections were stained for 20 min with 2% uranyl acetate, followed by lead citrate and viewed in a Hitachi H-500 electron microscope (Hitachi, Tokyo, Japan).
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Determination of cellular caspase-3 activity
Cellular caspase-3 activity was measured according to the Apoalert CPP32 Fluo-kit provided by Clontech (Palo Alto, CA, USA), in which caspase-3 activity was presented with fluorescent intensity (at 505 nm) of 7-amino-4-trifluoromethyl coumarin (AFC) after cleavage from the peptide substrate DEVD-AFC on luminescence spectrometer (Type LS 50B; PerkinElmer, Wellesley, MA, USA).
Determination of cellular glutathione (GSH) contents and anti-oxidant enzyme activity
A total of 10 7 cells were harvested, washed with ice-cold PBS and sonicated in the lysis buffer for 20 min. The homogenates were centrifuged at 10 000 g for 20 min at 4°C and the supernatants were used for the determination of cellular GSH contents and enzyme activity, which was performed with kits provided by the manufacturer (Nanjing Bioengineering Institution, Nanjing, PR China). Briefly, cellular glutathione Stransferase (GST) and glutathione peroxidase (Gpx) activities were determined respectively according to the reduction of GSH contents in the following reaction systems:
O. An activity unit of GST or Gpx was defined as decreasing 1.0 M GSH in 1 min. GSH contents were measured according to OD 420 nm values of a yellow compound that was produced by the reaction between GSH and disulfurate dinitrobenzyl acid. The catalase activity was measured according to its ability to decompose H 2 O 2 into H 2 O, and an activity unit of catalase was regarded as decomposing 1.0 M H 2 O 2 in 1 s. A nitrite unit of superoxide dismutase (SOD) activity was defined as 50% of SOD inhibition rate in 1 ml reaction solution, in which SOD specifically inhibited the activity of superoxide (O 2 − ) produced by the reaction of xanthine and xanthine oxidase, while O 2 − oxidized hydroxyamine into nitrite, the latter presenting purple color in the presence of the relative colorant. Cellular protein concentrations were determined by the Bradford method with bovine serum albumin as a standard.
Cell differentiation assays
Cell differentiation antigens CD11b, CD14 and CD33 were determined on flow cytometry (Coulter EPICS XL, South San Francisco, CA, USA). All fluorochrome-labeled monoclonal antibodies including anti-human CD11b/FITC, CD33/PE, CD14/FITC antibody and their corresponding isotypic control (IgG 1 /FITC, IgG 1 /PE, IgG 2a /FITC) were purchased from Coulter-Immunotech (Paris, France). In addition, NBT reduction and cytochemical reactions were done as previously described.
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Immunofluorescence analysis for PML/PML-RAR␣ proteins
Cells were centrifuged on to slides as described above and rapidly air-dried. Immunofluorescence staining of the Nterminal region of PML was performed using a high-quality anti-PML N-terminal antiserum, 5 kindly provided by Dr Naoe (Branch Hospital, School of Medicine, Nagoya University, Japan).
Reverse transcriptase polymerase chain reaction (RT-PCR)
Expression of some genes regulated by ATRA, including CD52, Bfl-1, RIG-E, preA-PAI-2, transglutaminase (TG), PKC type ␤ I (PKC ␤ I), SUMO-1 and RAR␤ were measured by RT-PCR in As 2 O 3 -and ATRA-treated NB4 cells. In brief, 4 g total RNAs, isolated from NB4 cells by using Trizol reagents (GIBCO BRL), were reverse transcribed with random primers with Superscript II RT (GIBCO BRL). PCR reactions were performed in 50 l solutions containing 1 l cDNA, 1 M primers, 200 M dNTPs, 2.5 units of Taq DNA polymerase, and 1.5 mM MgCl 2 , after denaturation (94°C, 5 min) as follows: 94°C, 1 min, 56°C, 1 min, 72°C 2.5 min, 30 cycles, followed by extension at 72°C for 10 min. All the PCR products were electrophoresed on a 2% agarose gel containing 0.5 g/ml ethidium bromide in 1× TAE buffer and visualized on a UVP transilluminator. G3PDH was used as an internal control for each sample.
Results
High-dose As 2 O 3 -induced ⌬⌿m collapse and apoptosis were associated with thiols in myeloid leukemic cell lines
As shown in Figure 1 , with double staining of PI and Rh123, most untreated NB4 cells presented negative PI (intact plasma membrane) and high Rh123 staining (normal ⌬⌿m). With treatment of 1.0 M As 2 O 3 for 1 to 3 days, NB4 cells with negative PI and low Rh123 staining (disrupted ⌬⌿m) presented a time-dependent increase. These changes appeared in parallel with 1.0 M As 2 O 3 -induced apoptosis in NB4 cells, which was confirmed by the decreased cell viability, typical apoptotic morphology, increased sub-G 1 cells and DNA ladder pattern in agarose gel ( Figure 1 and data not shown). TEM observation showed that these apoptotic cells presented dense mitochondrial matrix and condensed chromatin and fragmental nuclei (Figure 2a) . Furthermore, the activity of caspase-3 was significantly increased 12ෂ24 h after the treatment with 1.0 M, but not with 0.1 M As 2 O 3 ( Figure 2b ). As seen in As 2 O 3 -treated malignant lymphocytes, 18 0.2 mM DTT blocked, while 1.0 mM BSO enhanced As 2 O 3 -induced ⌬⌿m collapse, caspase-3 activation and apoptosis in NB4 cells (Figure 1 and Figure 2b) . A similar phenomenon also appeared in 1.0 M As 2 O 3 -treated MR2, R1 and R2 cells, which were sensitive to As 2 O 3 -induced apoptosis despite their resistance to ATRA (Figure 2c ). More interestingly, HL60 and U937 cells did not present ⌬⌿m collapse and apoptosis under treatment of 1.0 M As 2 O 3 alone, but these effects could be seen with simultaneous treatment of 1.0 M As 2 O 3 and 1.0 mM BSO (Figure 2c ).
As 2 O 3 -insensitive cells showed high level of cellular GSH contents or catalase activity
As mentioned above and previously, 5, 8, 11, 17, 18 HL-60, U937 and Jurkat cell line, a T lymphocytic lineage from T-ALL, had weak sensitivity to 1.0 M As 2 O 3 -induced apoptosis, which was enhanced by BSO. These results supported the concept that intracellular GSH level could be associated with the sensitivity of cells to As 2 O 3 -induced apoptosis, which had been reported by some groups. 25 However, only three cell lines were involved in the report. Therefore, we detected cellular GSH contents and the activity of four anti-oxidant enzymes of eight malignant hematopoietic cell lines. The results showed that Gpx, GST and SOD activities showed no significant differences among these cells. However, cells sensitive to As 2 O 3 -induced apoptosis had lower GSH level and catalase activity. Contrarily, Jurkat cells had the higher GSH level and HL-60 and U937 cells had significantly higher catalase activities (Figure 3 ). changed every day and corresponding concentrations of drugs were supplemented. As reported previously, 5 0.1 M As 2 O 3 induced partial differentiation of NB4 cells, as manifested by morphologic changes, increased expression of differentiation antigen CD11b without the significant changes of NBT reduction and CD33/CD14 expression. However, these differentiation-related alterations were not blocked by 0.2 mM DTT, and they were not present in ATRA-resistant NB4-derived sublines MR2, R1 and R2 with 0.1ෂ0.5 M As 2 O 3 treatment for more than 10 days (Figure 4 and data not shown). These findings encouraged us to hypothesize that As 2 O 3 -induced differentiation might be associated with retinoic acid (RA) and/or its receptor complex (RAR␣/RXR) signaling pathways. In order to confirm this hypothesis, we tried to perform the experiment in cell culture medium depleted of ATRA, prepared with charcoal-treated FBS. Unfortunately, cells could not maintain the survival for the sufficient length of time (7ෂ14 days) in our experimental conditions. We then speculated that if As 2 O 3 -induced differentiation was associated with RAR␣/RXR signaling pathways As 2 O 3 should also be able to induce differentiation of HL60 cells, which are very sensitive to the differentiation-inducing effect of ATRA. Surprisingly, 0.1ෂ0. 
Low-dose As
As 2 O 3 and ATRA at low dose yielded similar gene expression profiles in APL cells
A study in our group showed that a large number of genes could be regulated during the APL cell differentiation induced by pharmacological concentrations of ATRA. 26 To further test the hypothesis that mechanisms of As 2 O 3 -induced differentiation could be related to RA and/or RAR␣/RXR signaling pathways, the expression of a group of selected ATRA-responsive genes was measured by RT-PCR in As 2 O 3 -treated NB4 cells. Cells treated with 10 −8 M and 10 −9 M ATRA were used as controls. As shown in Figure 6 , both 0.1 M As 2 O 3 and low concentrations of ATRA yielded similar mRNA expression profiles in most genes tested, including the upregulation of CD52 and Bf1-1, the downregulation of RAR␤, and no modulation of RIG-E and Pre A-PAI-2. In addition, synergistic effects were observed in the regulation of PKC␤-1 and SUMO-1 when cells were under the simultaneous treatment of 0.1 M As 2 O 3 and 10 −8 M ATRA.
Figure 3
Constitutive levels of cellular GSH content and the antioxidant enzyme activities in eight cell lines. In these cell lines, RPMI8226 and Namalwa cells, which are derived respectively from Burkitt's lymphoma and multiple lymphoma, are sensitive to As 2 O 3 -induced apoptosis, like NB4, MR2 and R2 cells. The other three cell lines had weaker responses to As 2 O 3 -induced apoptosis. 
Effects of DTT on PML/PML-RAR␣ protein degradation induced by high or low concentrations of As 2 O 3
To examine the possible role of −SH groups in As 2 O 3 -induced modulation/degradation of PML/PML-RAR␣ proteins, immunofluorescence analysis with anti-PML antibody was performed in NB4 cells treated simultaneously with DTT and As 2 O 3 . 0.2 mM DTT treatment alone did not significantly modulate subcellular localization of PML/PML-RAR␣ proteins, but it visibly inhibited the rapid effects of 1.0 M As 2 O 3 on the degradation of PML/PML-RAR␣ proteins. Also, 0.2 mM DTT treatment over 10 days seemed to have some inhibitory effect, to a lesser extent, on the degradation of PML/PML-RAR␣ proteins induced by 0.1 M As 2 O 3 ( Figure 7 ).
M As 2 O 3 did not induce apoptosis, while 0.1 M
As 2 O 3 induced cell differentiation in fresh cells from a de novo APL patient
We previously described that dose-dependent dual effects of As 2 O 3 were also seen in fresh APL cells, but the responses of cells from different patients exhibited significant heterogeneity. 5 In line with this preliminary observation, the experiment performed here on fresh cells from two de novo APL patients showed quite different dose-responses. Cells from one patient, like NB4 cells, experienced significant ⌬⌿m collapse and apoptosis under 1.0 M As 2 O 3 , which could be abrogated by 0.2 mM DTT (data not shown). Surprisingly, in fresh BM cells from another de novo APL patient, 1.0 M As 2 O 3 did not induce ⌬⌿m collapse and apoptosis (Figure 8a ). However, a partial differentiation was induced by 0.1 M As 2 O 3 which was corroborated by morphology (data not shown) and CD11b expression (Figure 8b Res cells) and NBT reduction (e). Treatment time (day, d) and drug doses are shown in the figure. All data were confirmed by three independent experiments.
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Figure 6
Effects 
Discussion
In this work, 1.0 M As 2 O 3 markedly induced ⌬⌿m collapse, ultracondensation of the mitochondrial matrix and activation of caspase-3 in ATRA-sensitive and ATRA-resistant APL cell lines, which were coupled with As 2 O 3 -induced apoptosis. Furthermore, DTT substantially blocked, while BSO enhanced, As 2 O 3 -induced ⌬⌿m collapse and apoptosis of APL cells. Interestingly, BSO could also render HL60 and U937 cells sensitive to As 2 O 3 -induced apoptosis. These observations further supported our previous conclusion that ⌬⌿m collapse was an important mechanism in As 2 O 3 -induced apoptosis, and −SH groups might be an important chemosensor of As 2 O 3 for the induction of ⌬⌿m collapse and apoptosis. 18 Although mitochondria were involved with As 2 O 3 -induced apoptosis, 1.0 M As 2 O 3 did not induce ⌬⌿m collapse and apoptosis in HL60, U937 cells and Jurkat cells. 5, 8, 11, 17, 18 It is thus of interest to understand how these cells escape the death pathways in order to explore clinical effectiveness of As 2 O 3 in cancers other than APL. We showed that HL60, U937 and Jurkat cells resistant to As 2 O 3 had either high cellular catalase activity or high GSH level, while their sensitivities to As 2 O 3 were restored due to GSH depletion. These facts suggested that catalase activity was also very important for the sensitivity of cells to As 2 O 3 in addition to intracellular GSH content. 25 Of note, a recent report showed that 1.0 M As 2 O 3 could induce apoptosis of HL60 cells. 27 We believe that the most likely reason for the discrepancy between this datum and most reports. 5, 8, 11, 17, 18 was the variation of cell lines with regard to some critical genetic or biochemical regulation, eg the oxidation and anti-oxidation capacities. Also, As 2 O 3 was widely shown to trigger reorganization and degradation of the PML/PML-RAR␣ proteins, which could be related to the striking increase of SUMO-1-PML conjugates induced by As 2 O 3 . 28 Here, we showed that DTT inhibited As 2 O 3 -induced degradation of PML/PML-RAR␣ proteins, in parallel with the inhibition of As 2 O 3 -induced apoptosis. Moreover, trivalent antimonial-provoked apoptosis was also coupled with the degradation of PML-RAR␣ proteins and the reorganization of the PML nuclear bodies (NBs) in APL cells. 29 In addition, As 2 O 3 did not induce apoptosis of primary APL blasts with the expression of PLZF-RAR␣ fusion proteins. 30 Based on these observations, further consideration that the modulation/ degradation of PML/PML-RAR ␣ influences the sensitivity of APL cells to As 2 O 3 -induced apoptosis, is deserved, although As 2 O 3 has a wider spectrum in terms of apoptosis induction.
We previously suggested that low-dose As 2 O 3 -induced cell differentiation could be an even more important factor for the remission induction of APL. 5 In this study, DTT did not block 0.1 M As 2 O 3 -induced partial differentiation in NB4 cells. Interestingly, fresh cells from one de novo APL patient were resistant to 1.0 M As 2 O 3 -induced apoptosis but sensitive to 0.1 M As 2 O 3 -induced differentiation. Obviously, independent mechanisms were involved in As 2 O 3 -induced apoptosis and differentiation, which was also supported by data from an arsenic-resistant NB4 subline (NB4-AsR) which failed to undergo apoptosis, but maintained partial differen-
Figure 9
A hypothesis for mechanisms of As 2 O 3 in the treatment of APL. As 2 O 3 may induce remission in APL patients via inducing partial differentiation and triggering apoptosis. High-dose (1ෂ2 M) As 2 O 3 induces APL cell apoptosis through direct or indirect disruption of mitochondrial transmembrane potentials due to opening of permeability transmission (PT) pores. This leads to release of pro-apoptosis factors such as cytochrome C and apoptosis-inducing factor (AIF) from mitochondria to cytoplasma, where they activate caspase and degradate specific substrates. Low-dose (0.1ෂ0.5 M) As 2 O 3 , in contrast, induces partial differentiation of APL cells through direct or indirect activation of RAR␣/RXR pathways, in which coactivator (CoAct) and histone acetylase (HAC) are involved. Then, activated RAR␣/RXR binds to retinoic acid response elements (RARE) and induces the expression of differentiation-related genes. →, stimulation, ٜ inhibition. tiation response to As 2 O 3 .
7 However, the mechanisms of As 2 O 3 -induced differentiation are elusive so far. Previously, we suggested that like ATRA, As 2 O 3 -induced differentiation of APL blasts was associated with the degradation of the PML-RAR␣ proteins. 5 However, we revealed in this study that As 2 O 3 could also induced partial differentiation of HL60 cells where no dominant negative chimeric receptor is present, and DTT did not block As 2 O 3 -induced differentiation but partly inhibited As 2 O 3 -induced PML-RAR␣ modulation in NB4 cells. These facts indicated that the modulation/degradation of PML-RAR␣ proteins is not the only mechanism of As 2 O 3 -induced differentiation. In fact, the role of PML-RAR␣ in ATRAinduced differentiation is controversial. of ATRA, although the similarity of gene regulation between 0.1 M As 2 O 3 and ATRA could also be associated with modulation/degradation of PML-RAR␣ proteins induced by them. These important findings prompted us to speculate that low-dose As 2 O 3 also provides direct or indirect stimulation to wild-type RAR␣/RXR signaling pathways, especially in the presence of degradation of PML-RAR␣ proteins, which blocked differentiation and apoptosis of APL cells. Figure 9 represents our working hypothesis for the mechanism of action of As 2 O 3 in remission induction of APL, although some aspects remain to be confirmed at the molecular level: As 2 O 3
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induces remission of APL patients via two independent pathways, that is, triggering partial differentiation and inducing apoptosis. High-dose As 2 O 3 -induced apoptosis involves mainly the sulfhydryl group-related ⌬⌿m collapse due to the opening of PT pore, which triggers the release of pre-apoptotic factor from mitochondria to cytoplasma, followed by caspase activation and degradation of specific substrates. On the other hand, low-dose As 2 O 3 -induced differentiation might be mediated directly or indirectly by RAR␣-related signaling pathway(s), in which nuclear receptor coactivators/ corepressors and histone acetylation are involved.
